Yoneda T - Search Results

1

Crosstalk between cancer cells and bone microenvironment in bone metastasis.

Yoneda T, Hiraga T. Yoneda T, et al. Biochem Biophys Res Commun. 2005 Mar 18;328(3):679-87. doi: 10.1016/j.bbrc.2004.11.070. Biochem Biophys Res Commun. 2005. PMID: 15694401 Review.

2

The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs.

Michigami T, Hiraga T, Williams PJ, Niewolna M, Nishimura R, Mundy GR, Yoneda T. Michigami T, et al. Among authors: yoneda t. Breast Cancer Res Treat. 2002 Oct;75(3):249-58. doi: 10.1023/a:1019905111666. Breast Cancer Res Treat. 2002. PMID: 12353814

3

Bisphosphonate actions on bone and visceral metastases.

Yoneda T, Hashimoto N, Hiraga T. Yoneda T, et al. Cancer Treat Res. 2004;118:213-29. doi: 10.1007/978-1-4419-9129-4_10. Cancer Treat Res. 2004. PMID: 15043195 Review. No abstract available.

4

Use of bisphosphonates for the treatment of bone metastasis in experimental animal models.

Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T. Yoneda T, et al. Cancer Treat Rev. 1999 Oct;25(5):293-9. doi: 10.1053/ctrv.1999.0133. Cancer Treat Rev. 1999. PMID: 10544073 Review.

5

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma.

Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T. Yoneda T, et al. Cancer. 2000 Jun 15;88(12 Suppl):2979-88. doi: 10.1002/1097-0142(20000615)88:12+<2979::aid-cncr13>3.0.co;2-u. Cancer. 2000. PMID: 10898341 Review.

6

Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment.

Mundy GR, Yoneda T, Hiraga T. Mundy GR, et al. Among authors: yoneda t. Semin Oncol. 2001 Apr;28(2 Suppl 6):35-44. doi: 10.1016/s0093-7754(01)90263-5. Semin Oncol. 2001. PMID: 11346863 Review.

7

The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

Hiraga T, Williams PJ, Mundy GR, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Cancer Res. 2001 Jun 1;61(11):4418-24. Cancer Res. 2001. PMID: 11389070

8

A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.

Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. Yoneda T, et al. J Bone Miner Res. 2001 Aug;16(8):1486-95. doi: 10.1359/jbmr.2001.16.8.1486. J Bone Miner Res. 2001. PMID: 11499871 Free article.

9

C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.

Myoui A, Nishimura R, Williams PJ, Hiraga T, Tamura D, Michigami T, Mundy GR, Yoneda T. Myoui A, et al. Among authors: yoneda t. Cancer Res. 2003 Aug 15;63(16):5028-33. Cancer Res. 2003. PMID: 12941830

10

Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.

Hiraga T, Myoui A, Choi ME, Yoshikawa H, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Cancer Res. 2006 Feb 15;66(4):2067-73. doi: 10.1158/0008-5472.CAN-05-2012. Cancer Res. 2006. PMID: 16489006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,015 results

Search Page

Filters